Study of Cognitive Screening and Multidomain Treatment to Prevent Cognitive Decline in Older Adults with Type 2 Diabetes

What this Trial Is About

Researchers are investigating how common cognitive impairment is among older adults with type 2 diabetes and are evaluating a multidomain intervention aimed at preventing cognitive decline in this group. Type 2 diabetes is linked to worsening brain function and higher risks of Alzheimers and vascular dementia, which complicates diabetes management. This study aims to improve understanding and care by screening for cognitive issues and testing new ways to slow decline. The study has two parts first, a prevalence study with cognitive screening for older adults with type 2 diabetes, and second, a two-year randomized controlled trial comparing a multidomain intervention to usual care. The intervention includes optimizing medications, adjusting blood sugar targets, managing vascular risks, assessing hearing and depression, promoting physical and cognitive training, using dialogue tools, social interaction, and sending text reminders to support health and adherence. Participants will undergo cognitive tests and assessments, with researchers monitoring changes in cognitive function, hospitalizations, and quality of life over two years. The study will gather data on medication adherence and other health outcomes, aiming to offer evidence-based recommendations for future diabetes and cognitive care. The total participation includes screening and follow-up evaluations to track the interventions impact and safety.

Cognitive Screening and Multidomain Intervention Targeting Cognitive Decline in Type 2 Diabetes (The Brain Care Study)